Category: Drug safety and pharmacovigilance
This category dedicated to the topics of drug safety and pharmacovigilance, with several subcategories available for exploration. Feel free to browse the various subcategories according to your interests.
-
π Decoding Personal Data in Pharmacovigilance Reporting
In this comprehensive blog, you’ll learn everything about handling personal data within pharmacovigilance reporting, along with crucial insights. Stay tuned for more updates!
-
π Spontaneous Reports: A Key Component of Pharmacovigilance
This blog includes: Introduction In the context of data collection, multiple report types contribute to the generation of safety reports. However, one source stands out for being less organized and accumulating large data, i.e, spontaneous reports. It significantly impacts the risk and benefit profile of drug safety. This section will explore this reporting system and…
-
γ Solicited Reports vs Unsolicited Reports: Key Differences
This blog provides specific information on: Introduction In this write-up, you will have clarity from: Many people believe in a wrong way that solicited and unsolicited refer to the sources of reports, but that is not the case. Here, you will find detailed explanations to help you understand these concepts. Definitions Solicited Reports: These reports…
-
π CAPA Cases in Pharmacovigilance: An Overview
In this detailed blog, we explore into CAPA cases, their workflow, and their significance within pharmacovigilance. Explore further to gain a deeper understanding of how to effectively manage CAPA within this context.
-
β Thalidomide incident and pharmaceutical industry
Welcome to our comprehensive blog where we delve into the transformative impact of thalidomide and its lasting influence on the cost burden of drugs in our society today. Gain a deep understanding of how the incident reshaped the way we approach drug development, testing, and regulation.
-
π₯Ά Adverse Drug Reactions vs Adverse Event: The differences
In this blog, we address the common confusion between adverse reactions and adverse events. We aim to clarify the distinction between these terms that often perplex many individuals. If you are still uncertain about the difference, this blog provides the perfect opportunity to gain clarity and enhance your understanding.
-
π Investigational Brochure (IB): An Overview
Welcome to our informative article, where we unravel the concept of the Investigational Brochure (IB). In this comprehensive piece, we aim to provide a clear understanding of what an IB is, its purpose, significance, and the important components it comprises.
-
ποΈ Understanding Temporal Relationships in Pharmacovigilance
In this comprehensive blog post, we explore into the concept of temporal relationships within pharmacovigilance, particularly focusing on assessing causality. The discussion includes important insights and illustrative examples to enhance understanding.